Privia Health Group, Inc. (PRVA) is an innovative platform focused on value-based care. The company revolves around its mission to provide better, more coordinated care to the patients it serves, with the ultimate goals of improving overall patient outcomes, enhancing their care experience, and controlling healthcare costs.
The healthcare company is publicly traded under the ticker symbol PRVA on the NASDAQ stock exchange. Privia Health utilizes a patient-centric, physician-driven, cloud-based approach offering services through technology and team-based care. The company operates through two segments, Privia Health Network and Privia Quality Network.
Privia Health has established itself as a disruptive presence in the healthcare industry through its cloud-based technology, which empowers physicians to manage their practices, manage patient health records, deliver virtual healthcare services, and measure and improve performance. With a core belief that the best healthcare is local, the company partners with top primary care physicians and specialists to enhance their practices through technology and support services, which provides their patients with improved healthcare experiences.
By creating collaborative ecosystems with high-performing health systems, health plans, and provider groups, Privia Health integrates tailored population health strategies into its model of care, thereby improving member care quality, reducing overall member costs, and driving consistent member engagement.
As well as serving physicians and patients, Privia Health Group, Inc. also works with health plans to create customized solutions that support their members. This includes proactive health management, comprehensive care coordination, and risk adjustment services. The company's proprietary performance platform, population health initiatives, and risk-adjustment expertise ensure that their health plan partners stay ahead of their competitors.
Making significant strides in the healthcare industry, Privia Health Group, Inc. has become a leading provider of medical and management services, delivering care efficiency, patient satisfaction, and improved health outcomes. Through a combination of advanced technology, innovative solutions, and a patient-focused approach, Privia Health aims to redefine the future of healthcare delivery.
With well over 600,000 patients strong, Privia Health assists physicians in the transition to a more sustainable, high-quality, and efficient health care delivery method. The company's true value revolves around its ability to improve the healthcare experience for the physicians and patients it serves along with the added benefit of driving down overall costs. As a pioneer and leader in healthcare delivery, Privia Health Group, Inc. continues to redefine value-based care by directly addressing today's healthcare challenges by delivering industry-leading solutions.
Income statement
Balance sheet statement
Cash flow statement
Current assets / Current liabilities
Equity / Debt / Cash
Dividends
Argus has lowered its target price for Privia Health Group, Inc. (PRVA) to $18.00. The current stock price for PRVA is $19.71. Privia Health Group Inc. is described as a technology-driven, national physician-enablement company.
Privia Health Group (PRVA) stock closed at US$19.85, but its P/E ratio of 90.2x is significantly higher than the healthcare sector average of 24.0x, suggesting it is overvalued based on current earnings. Despite a 23.1% fall in share price over the past five years, the market is paying a rich premium for its current profits. Simply Wall St's analysis indicates that the stock is overvalued when compared to a tailored benchmark considering its growth profile, margins, size, and risk.
Privia Health Group Inc. (NASDAQ: PRVA) is showing weak near and mid-term sentiment but a neutral long-term outlook, with its support levels currently being tested. The article details three AI-generated trading strategies—Position Trading, Momentum Breakout, and Risk Hedging—each tailored to different risk profiles and offering specific entry, target, and stop-loss zones. Despite the weak sentiment, an exceptional 41.8:1 risk-reward setup is identified, targeting a 12.4% gain against a 0.3% risk.
This article analyzes Privia Health Group Inc. (NASDAQ: PRVA), highlighting weak near and mid-term sentiment but a neutral long-term outlook. It identifies key support and resistance levels, presenting an exceptional risk-reward setup. The piece also outlines three distinct AI-generated trading strategies—Position Trading, Momentum Breakout, and Risk Hedging—tailored for different risk profiles.
Privia Health Group (PRVA) recently reported strong Q2 2026 results with increased sales and profitability, raising its full-year 2026 GAAP revenue outlook to the high end of its prior range. The company also appointed Dr. Opella Ernest to its Board, bringing valuable healthcare expertise. Investors should consider how this stronger guidance and new board addition impact Privia's investment narrative, particularly concerning its ability to manage rising costs and scale its value-based care model.
Privia Health Group, Inc. has announced the appointment of Opella Ernest, M.D. to its Board of Directors, effective September 1, 2026. Dr. Ernest, who brings over 20 years of healthcare executive experience and significant value-based care and clinical expertise, will also join the Compliance Committee. Her experience as President, HCSC Markets at Health Care Service Corporation and her background as a board-certified family physician are expected to be beneficial for Privia Health's continued growth.